Skip to main content
. 2019 Oct 31;10:1061. doi: 10.3389/fgene.2019.01061

Table 2.

Patients with rare substitutions in AD-PD-associated genes.

Patient ID Form AOO Sex Symptoms Gene Variant ID Zygosity Clinical significance ACMG classification MAF Patients Controls Reference
P15 F 25 f tremor, slower and altered handwriting, depression, anxiety LRRK2 L1795F
c.5385G>T
rs111910483
het P LP <0.01 1/142 0/117 (Nichols et al., 2007)
P123 F 34 m hypomimia, tremor, rigidity, bradykinesia, postural instability, freezing, depression LRRK2 Y1649S
c.4946A>C
het D LP 1/142 0/117 *
P46 F 30 m tremor, rigidity, bradykinesia, decreased synkinesis of arms, depression DNAJC13 L2170W
c.6509T>G
rs140537885
het D/RF US <0.01 2/54 0/117 (Gustavsson et al., 2015)
P2 F 33 f tremor, decreased synkinesis of arms EIF4G1 M1356T
c.4067T>C
rs144059151
het D US <0.01 1/54 0/117 *

For minor allele frequency (MAF), we used the gnomAD database non-neuro group (v2.1) of European population (non-Finnish). F, familiar aggregatio; f, female; m, male; LRRK2, leucine rich repeat kinase 2; DNAJC13, DnaJ heat shock protein family (Hsp40) member C13; EIF4G1, eukaryotic translation initiation factor 4 gamma 1; het, heterozygous; P, pathogenic; D, damaging; RF, risk factor; ACMG, American College of Medical Genetics; LP, likely pathogenic; US, uncertain significance; AOO, age of onset; MAF, minor allele frequency. *Firstly reported in this study.